The cholinergic system in aging and neuronal degeneration

Schliebs, 2006, The significance of the cholinergic system in the brain during aging and in Alzheimer's disease, J Neural Transm, 113, 1625, 10.1007/s00702-006-0579-2

Berger-Sweeney, 2003, The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers, Neurosci Behav Rev, 27, 401, 10.1016/S0149-7634(03)00070-8

Bigl, 1990, The nucleus basalis of Meynert during aging and in dementing neuropsychiatric disorders, 364

Härtig, 2002, Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?, Rev Neurosci, 13, 95, 10.1515/REVNEURO.2002.13.2.95

Bergmann, 1997, Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75, Eur J Neurosci, 9, 18, 10.1111/j.1460-9568.1997.tb01349.x

Dekker, 1991, NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis, Neuroreport, 2, 577, 10.1097/00001756-199110000-00006

Hefti, 1985, Nerve growth factor increases choline acetyltransferase but not survival or fibre outgrowth of cultured fetal septal cholinergic neurons, Neuroscience, 14, 55, 10.1016/0306-4522(85)90163-0

Williams, 1986, Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection, Proc Natl Acad Sci U S A, 83, 9231, 10.1073/pnas.83.23.9231

Wilcox, 1995, Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons, J Comp Neurol, 359, 573, 10.1002/cne.903590405

Winkler, 2000, Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors, J Neurosci, 20, 834, 10.1523/JNEUROSCI.20-02-00834.2000

Katoh-Semba, 1998, Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3, Neurosci Res, 31, 227, 10.1016/S0168-0102(98)00040-6

Cooper, 1994, Reduced transport of 125I-NGF by cholinergic neurons and downregulated TrkA expression in the medial septum of aged rats, Neuroscience, 62, 625, 10.1016/0306-4522(94)90462-6

DeLacalle, 1996, Reduced retrograde labeling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats, Neuroscience, 75, 19, 10.1016/0306-4522(96)00239-4

Sofroniew, 2001, Nerve growth factor signaling, neuroprotection, and neural repair, Annu Rev Neurosci, 24, 1217, 10.1146/annurev.neuro.24.1.1217

Koliatsos, 1991, Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates, Ann Neurol, 30, 831, 10.1002/ana.410300613

Tuszynski, 2000, Intraparenchymal NGF infusions rescue degenerating cholinergic neurons, Cell Transplant, 9, 629, 10.1177/096368970000900508

Emerich, 1994, Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons, J Comp Neurol, 349, 148, 10.1002/cne.903490110

Tuszynski, 1996, Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration, Gene Ther, 3, 305

Chen, 1995, Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion, Neuroscience, 68, 19, 10.1016/0306-4522(95)00099-5

Markowska, 1994, Human nerve growth factor improves spatial memory in aged but not in young rats, J Neurosci, 14, 4815, 10.1523/JNEUROSCI.14-08-04815.1994

Eriksdotter-Jönhagen, 1998, Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease, Dement Geriatr Cogn Disord, 9, 246, 10.1159/000017069

Tuszynski, 2005, A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease, Nat Med, 11, 551, 10.1038/nm1239

Nagahara, 2009, Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery, Exp Neurol, 215, 153, 10.1016/j.expneurol.2008.10.004

Contestabile, 2008, The place of choline acetyltransferase activity measurement in the “cholinergic hypothesis” of neurodegenerative diseases, Neurochem Res, 33, 318, 10.1007/s11064-007-9497-4

Burke, 2006, Neural plasticity in the ageing brain, Nat Rev Neurosci, 7, 30, 10.1038/nrn1809

Coleman, 2005, Axon degeneration mechanisms: commonality amid diversity, Nat Rev Neurosci, 6, 889, 10.1038/nrn1788

Rapp, 1996, Preserved neuron number in the hippocampus of aged rats with spatial learning deficits, Proc Natl Acad Sci U S A, 93, 9926, 10.1073/pnas.93.18.9926

Rasmussen, 1996, Memory impaired aged rats: no loss of principal hippocampal and subicular neurons, Neurobiol Aging, 17, 143, 10.1016/0197-4580(95)02032-2

Smith, 2004, Memory impairment in aged primates is associated with focal death of cortical neurons and atrophy of subcortical neurons, J Neurosci, 24, 4373, 10.1523/JNEUROSCI.4289-03.2004

Ypsilanti, 2008, The length of hippocampal cholinergic fibres is reduced in the aging brain, Neurobiol Aging, 29, 1666, 10.1016/j.neurobiolaging.2007.04.001

Niewiadomska, 2006, Cytoskeletal transport in the aging brain: focus on the cholinergic system, Rev Neurosci, 17, 581, 10.1515/REVNEURO.2006.17.6.581

Small, 2004, Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging, Proc Natl Acad Sci U S A, 101, 7181, 10.1073/pnas.0400285101

Williams, 2007, Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation, Neurosci Lett, 413, 110, 10.1016/j.neulet.2006.11.040

Mattson, 2006, Aging and neuronal vulnerability, Nat Rev Neurosci, 7, 278, 10.1038/nrn1886

Woolf, 1989, The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease, Neurosci Lett, 96, 277, 10.1016/0304-3940(89)90391-1

McKinney, 2005, Brain cholinergic vulnerability: relevance to behavior and disease, Biochem Pharmacol, 70, 1115, 10.1016/j.bcp.2005.05.019

Arendt, 1988, Cholinergic-rich brain transplants reverse alcohol-induced memory deficits, Nature, 332, 448, 10.1038/332448a0

Fass, 2000, Differential vulnerability of primary cultured cholinergic neurons to nitric oxide excess, Neuroreport, 11, 931, 10.1097/00001756-200004070-00007

Julka, 1995, Altered cholinergicmetabolism in rat CNS following aluminum exposure: implications on learning performance, J Neurochem, 65, 2157, 10.1046/j.1471-4159.1995.65052157.x

Olesen, 1998, Amyloid beta neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells, Brain Res Mol Brain Res, 57, 266, 10.1016/S0169-328X(98)00096-5

Szutowicz, 2006, Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs, Metab Brain Dis, 21, 149, 10.1007/s11011-006-9007-4

Baskerville, 2008, Aging elevates metabolic gene expression in brain cholinergic neurons, Neurobiol Aging, 29, 1874, 10.1016/j.neurobiolaging.2007.04.024

Davies, 1976, Selective loss of central cholinergic neurons in Alzheimer's disease, Lancet, 2, 1403, 10.1016/S0140-6736(76)91936-X

Bowen, 1976, Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies, Brain, 99, 459, 10.1093/brain/99.3.459

Perry, 1977, Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue, J Neurol Sci, 34, 247, 10.1016/0022-510X(77)90073-9

Perry, 1977, Necropsy evidence of central cholinergic deficits in senile dementia, Lancet, 1, 189, 10.1016/S0140-6736(77)91780-9

Bierer, 1995, Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits, J Neurochem, 64, 749, 10.1046/j.1471-4159.1995.64020749.x

Gsell, 2004, Functional neurochemistry of Alzheimer's disease, Curr Pharmacol Design, 10, 265, 10.2174/1381612043386473

Nordberg, 1992, Neuroreceptor changes in Alzheimer disease, Cerebrovasc Brain Met Rev, 4, 303

Bartus, 2000, On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis, Exp Neurol, 163, 495, 10.1006/exnr.2000.7397

Mufson, 2008, Cholinergic system during the progression of Alzheimer's disease: therapeutic implications, Exp Rev Neurother, 8, 1703, 10.1586/14737175.8.11.1703

Rinne, 2003, Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease, J Neurol Neurosurg Psychiatry, 74, 113, 10.1136/jnnp.74.1.113

Shinotoh, 2000, Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study, Ann Neurol, 48, 194, 10.1002/1531-8249(200008)48:2<194::AID-ANA9>3.0.CO;2-X

Davis, 1999, Cholinergic markers in elderly patients with early signs of Alzheimer disease, JAMA, 281, 1401, 10.1001/jama.281.15.1401

Tiraboschi, 2000, The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease, Neurology, 55, 1278, 10.1212/WNL.55.9.1278

Gilmor, 1999, Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease, J Comp Neurol, 411, 693, 10.1002/(SICI)1096-9861(19990906)411:4<693::AID-CNE13>3.0.CO;2-D

DeKosky, 2002, Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment, Ann Neurol, 51, 145, 10.1002/ana.10069

Counts, 2005, The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease, J Neuropathol Exp Neurol, 64, 263, 10.1093/jnen/64.4.263

Kordower, 2001, Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment, Ann Neurol, 49, 202, 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.0.CO;2-3

Gómez-Isla, 1996, Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease, J Neurosci, 16, 4491, 10.1523/JNEUROSCI.16-14-04491.1996

Savaskan, 2001, Molecules involved in reactive sprouting in the hippocampus, Rev Neurosci, 12, 195, 10.1515/REVNEURO.2001.12.3.195

Mufson, 2007, Cholinotrophic molecular substrates of mild cognitive impairment in the elderly, Curr Alzheimer Res, 4, 340, 10.2174/156720507781788855

Auld, 2002, Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies, Prog Neurobiol, 68, 209, 10.1016/S0301-0082(02)00079-5

Picciotto, 2002, Nicotinic receptors in aging and dementia, J Neurobiol, 53, 641, 10.1002/neu.10102

Cuello, 2007, NGF-cholinergic dependency in brain aging. MCI and Alzheimer's disease, Curr Alzheimer Res, 4, 351, 10.2174/156720507781788774

Grön, 2006, Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis, Neurobiol Aging, 27, 78, 10.1016/j.neurobiolaging.2004.12.005

Goekoop, 2006, Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation – a pharmacological fMRI study, Brain, 129, 141, 10.1093/brain/awh671

Caccamo, 2009, M1 agonists as a potential disease-modifying therapy for Alzheimer's disease, Curr Alzheimer Res, 6, 112, 10.2174/156720509787602915

Martínez, 2009, Advances in Alzheimer therapy: understanding pharmacological approaches to the disease, Curr Alzheimer Res, 6, 83, 10.2174/156720509787602924

Pepeu, 2009, Cholinesterase inhibitors and beyond, Curr Alzheimer Res, 6, 86, 10.2174/156720509787602861

Arendt, 1983, Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease, Acta Neuropathol (Berl), 61, 101, 10.1007/BF00697388

Jellinger, 2000, Morphological substrates of mental dysfunctions in Lewy body disease: an update, J Neural Transm Suppl, 59, 185

Whitehouse, 1983, Basal forebrain neurons in the dementia of Parkinson disease, Ann Neurol, 13, 243, 10.1002/ana.410130304

Arendt, 1984, Neurone loss in the nucleus basalis of Meynert in Creutzfeldt–Jakob disease, Acta Neuropathol (Berl), 65, 85, 10.1007/BF00689832

Arendt, 1994, Impairment in memory function and neurodegenerative changes in the cholinergic basal forebrain system induced by chronic intake of ethanol, J Neural Transm Suppl, 44, 173

Bohnen, 2003, Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer's disease: an in vivo positron tomography study, Arch Neurol, 60, 1745, 10.1001/archneur.60.12.1745

Terry, 2003, The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development, J Pharmacol Exp Ther, 306, 821, 10.1124/jpet.102.041616

Salmond, 2005, Cognitive sequelae of head injury: involvement of basal forebrain and associated structures, Brain, 128, 189

Donat, 2010, Effects of lateral fluid percussion injury on cholinergic markers in the newborn piglet brain, Int J Dev Neurosci, 28, 31, 10.1016/j.ijdevneu.2009.10.001

Yan, 2004, Alzheimer's disease: interactions between cholinergic functions and β-amyloid, Curr Alzheimer Res, 1, 241, 10.2174/1567205043331992

Klein, 1999, Neurotoxicity and oxidative damage of β-amyloid 1–42 versus β-amyloid 1–40 in the mouse cerebral cortex, Ann NY Acad Sci, 893, 314, 10.1111/j.1749-6632.1999.tb07845.x

Walsh, 2007, Aβ oligomers – a decade of discovery, J Neurochem, 101, 1172, 10.1111/j.1471-4159.2006.04426.x

Cleary, 2005, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat Neurosci, 8, 79, 10.1038/nn1372

McLean, 1999, Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann Neurol, 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M

Schliebs, 2005, Basal forebrain cholinergic dysfunction in Alzheimer's disease – interrelationship with β-amyloid, inflammation and neurotrophin signaling, Neurochem Res, 30, 895, 10.1007/s11064-005-6962-9

Apelt, 2002, Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein, Brain Res, 953, 17, 10.1016/S0006-8993(02)03262-6

Lüth, 2003, Degeneration of β-amyloid-associated cholinergic structures in transgenic APPSW mice, Brain Res, 977, 16, 10.1016/S0006-8993(03)02658-1

Klingner, 2003, Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with β-amyloid plaque pathology, Int J Dev Neurosci, 21, 357, 10.1016/j.ijdevneu.2003.08.001

Liskowsky, 2006, Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein, Int J Dev Neurosci, 24, 149, 10.1016/j.ijdevneu.2005.11.010

Bigl, 2003, Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology, J Neural Transm, 110, 77, 10.1007/s00702-002-0772-x

Hamel, 2004, Cholinergic modulation of the cortical microvascular bed, Prog Brain Res, 145, 171, 10.1016/S0079-6123(03)45012-7

De la Torre, 2002, Alzheimer disease as a vascular disorder: nosological evidence, Stroke, 33, 1152, 10.1161/01.STR.0000014421.15948.67

Kalaria, 2000, The role of cerebral ischemia in Alzheimer's disease, Neurobiol Aging, 21, 321, 10.1016/S0197-4580(00)00125-1

Kouznetsova, 2007, Role of cholinergic system in β-amyloid related changes of perivascular innervation of cerebral microvessels in transgenic Tg2576 Alzheimer-like mice, J Neurochem, 101, 63

Bürger, 2009, Vascular endothelial growth factor (VEGF) affects processing of the amyloid precursor protein and β-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain, Int J Dev Neurosci, 27, 517, 10.1016/j.ijdevneu.2009.06.011

Heinitz, 2006, Cholinotoxicity mediated by soluble oligomers of β-amyloid(1–42) differs from cholinotoxic effects of oxidative stress as revealed by gene expression analysis, J Neurochem, 98, 1930, 10.1111/j.1471-4159.2006.04015.x

Jörchel, 2008, Oligomeric β-amyloid(1–42) induces the expression of Alzheimer disease-relevant proteins in cholinergic SN56.B5.G4 cells as revealed by proteomic analysis, Int J Dev Neurosci, 26, 301, 10.1016/j.ijdevneu.2008.01.004

Burghaus, 2000, Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients, Mol Brain Res, 76, 385, 10.1016/S0169-328X(00)00031-0

Mousavi, 2003, Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease, Neuroscience, 122, 515, 10.1016/S0306-4522(03)00460-3

Martin-Ruiz, 1999, Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease, J Neurochem, 73, 1635, 10.1046/j.1471-4159.1999.0731635.x

Sparks, 1998, Immunohistochemical localization of nicotinic beta2 and alpha4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations, Neurosci Lett, 256, 151, 10.1016/S0304-3940(98)00794-0

Wevers, 1999, Nicotinic acetylcholine receptors in Alzheimer's disease, J Alzheimers Dis, 1, 207, 10.3233/JAD-1999-14-503

Aubert, 1992, Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases, J Neurochem, 58, 529, 10.1111/j.1471-4159.1992.tb09752.x

Flynn, 1986, Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal, J Neurochem, 47, 1948, 10.1111/j.1471-4159.1986.tb13113.x

Hellström-Lindahl, 1999, Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain, Mol Brain Res, 66, 94, 10.1016/S0169-328X(99)00030-3

Nordberg, 2001, Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications, Biol Psychiatry, 49, 200, 10.1016/S0006-3223(00)01125-2

Perry, 1995, Alteration in nicotine binding sites in Parkinson's disease. Lewy body dementia and Alzheimer's disease: possible index of early neuropathology, Neuroscience, 64, 385, 10.1016/0306-4522(94)00410-7

Rinne, 1991, A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease, Brain Res, 547, 167, 10.1016/0006-8993(91)90588-M

Shimohama, 1986, Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia, J Neurochem, 46, 288, 10.1111/j.1471-4159.1986.tb12960.x

Sugaya, 1990, Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease, J Neurosci Res, 27, 349, 10.1002/jnr.490270314

Buckingham, 2009, Nicotinic acetylcholine receptor signaling: roles in Alzheimer's disease and amyloid neuroprotection, Pharmacol Rev, 61, 39, 10.1124/pr.108.000562

Guan, 2001, Suppressed expression of nicotinic acetylcholine receptors by nanomolar β-amyloid peptides in PC12 cells, J Neural Transm, 108, 1417, 10.1007/s007020100017

Liu, 2001, β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons, Proc Natl Acad Sci U S A, 98, 4734, 10.1073/pnas.081553598

Wang, 2000, β-Amyloid(1-42) binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology, J Biol Chem, 275, 5626, 10.1074/jbc.275.8.5626

Wang, 2000, Amyloid peptide Aβ(1-42) binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors, J Neurochem, 75, 1155, 10.1046/j.1471-4159.2000.0751155.x

Nagele, 2002, Intracellular accumulation of β-amyloid(1-42) in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease, Neuroscience, 110, 199, 10.1016/S0306-4522(01)00460-2

Oddo, 2005, Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease, Proc Natl Acad Sci U S A, 102, 3046, 10.1073/pnas.0408500102

Qi, 2005, Oxidative stress induced by β-amyloid peptide(1–42) is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells, Neurochem Int, 46, 613, 10.1016/j.neuint.2005.02.007

Guan, 2003, Loss of nicotinic receptors induced by β-amyloid peptides in PC12 cells: possible mechanism involving lipid peroxidation, J Neurosci Res, 71, 397, 10.1002/jnr.10496

Fodero, 2004, α7-nicotinic acetylcholine receptors mediate an Aβ(1–42)-induced increase in the level of acetylcholinesterase in primary cortical neurones, J Neurochem, 88, 1186, 10.1046/j.1471-4159.2003.02296.x

Dineley, 2001, β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease, J Neurosci, 21, 4125, 10.1523/JNEUROSCI.21-12-04125.2001

Dineley, 2002, β-Amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes, J Biol Chem, 277, 25056, 10.1074/jbc.M200066200

Pettit, 2001, β-Amyloid (1–42) peptide directly modulates nicotinic receptors in the rat hippocampal slice, J Neurosci, 21, RC120, 10.1523/JNEUROSCI.21-01-j0003.2001

Tozaki, 2002, The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic Ach receptors and AMPA receptors, Biochem Biophys Res Commun, 294, 42, 10.1016/S0006-291X(02)00429-1

Grassi, 2003, Amyloid β(1–42) peptide alters the gating of human and mouse α-bungarotoxin-sensitive nicotinic receptors, J Physiol, 547, 147, 10.1113/jphysiol.2002.035436

Lee, 2003, Differential physiologic responses of α7 nicotinic acetylcholine receptors to β-amyloid1–40 and β-amyloid1–42, J Neurobiol, 55, 25, 10.1002/neu.10203

Blusztajn, 2000, The cholinergic neuronal phenotype in Alzheimer's disease, Metab Brain Dis, 15, 45, 10.1007/BF02680013

Bencherif, 2010, Alpha7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology?, Med Hypotheses, 74, 281, 10.1016/j.mehy.2009.09.011

Hu, 2008, Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1–42)-induced tau phosphorylation in PC12 cells, J Neurochem, 106, 1371, 10.1111/j.1471-4159.2008.05483.x

Dziewczapolski, 2009, Deletion of the α7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease, J Neurosci, 29, 8805, 10.1523/JNEUROSCI.6159-08.2009

Rabizadeh, 1994, Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity, Proc Natl Acad Sci U S A, 91, 10703, 10.1073/pnas.91.22.10703

Yaar, 2002, Amyloid β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling, J Biol Chem, 277, 7720, 10.1074/jbc.M110929200

Kuner, 1998, Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells, J Neurosci Res, 54, 798, 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.0.CO;2-T

Perini, 2002, Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines, J Exp Med, 195, 907, 10.1084/jem.20011797

Sotthibundhu, 2008, β-Amyloid(1–42) induces neuronal death through the p75 neurotrophin receptor, J Neurosci, 28, 3941, 10.1523/JNEUROSCI.0350-08.2008

Knowles, 2009, The p75 neurotrophin receptor promotes amyloid-β(1–42)-induced neuritic dystrophy in vitro and in vivo, J Neurosci, 29, 10627, 10.1523/JNEUROSCI.0620-09.2009

Morishima, 2001, β-Amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand, J Neurosci, 21, 7551, 10.1523/JNEUROSCI.21-19-07551.2001

Hashimoto, 2004, Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-β peptides via p75NTR/PLAIDD, J Neurochem, 90, 549, 10.1111/j.1471-4159.2004.02513.x

Yaar, 2007, A cyclic peptide that binds p75(NTR) protects neurones from β amyloid (1–40)-induced cell death, Neuropathol Appl Neurobiol, 33, 533, 10.1111/j.1365-2990.2007.00844.x

Kosik, 1986, Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proc Natl Acad Sci U S A, 83, 4044, 10.1073/pnas.83.11.4044

Lee, 1991, A68: a major subunit of paired helical filaments and derivatized forms of normal Tau, Science, 251, 675, 10.1126/science.1899488

Goedert, 2005, Mutations causing neurodegenerative tauopathies, Biochim Biophys Acta, 1739, 240, 10.1016/j.bbadis.2004.08.007

Hellström-Lindahl, 2000, Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists, J Neurochem, 74, 777, 10.1046/j.1471-4159.2000.740777.x

Wang, 2003, α7 nicotinic acetylcholine receptors mediate β-amyloid peptide-induced tau protein phosphorylation, J Biol Chem, 278, 31547, 10.1074/jbc.M212532200

Oddo, 2003, Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease, Neurobiol Aging, 24, 1063, 10.1016/j.neurobiolaging.2003.08.012

Billings, 2005, Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron, 45, 675, 10.1016/j.neuron.2005.01.040

Kitazawa, 2005, Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease, J Neurosci, 25, 8843, 10.1523/JNEUROSCI.2868-05.2005

Mufson, 2002, Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease, Neurochem Res, 27, 1035, 10.1023/A:1020952704398

Mesulam, 2004, The cholinergic lesion of Alzheimeŕs disease: pivotal factor or side show, Learn Mem, 11, 43, 10.1101/lm.69204

Forman, 2007, Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis, Neurology, 68, 757, 10.1212/01.wnl.0000256373.39415.b1

Ginsberg, 2006, Single cell gene expression profiling in Alzheimer's disease, NeuroRx, 3, 302, 10.1016/j.nurx.2006.05.007

Goedert, 1989, Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease, Neuron, 3, 519, 10.1016/0896-6273(89)90210-9

Goedert, 1989, Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain, EMBO J, 8, 393, 10.1002/j.1460-2075.1989.tb03390.x

Ginsberg, 2006, Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease, J Neurochem, 96, 1401, 10.1111/j.1471-4159.2005.03641.x

Geula, 2008, Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease, J Neuropathol Exp Neurol, 67, 309, 10.1097/NEN.0b013e31816a1df3

Sassin, 2000, Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert, Acta Neuropathol, 100, 259, 10.1007/s004019900178

Belarbi, 2009, Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease, Curr Alzheimer Res, 6, 152, 10.2174/156720509787602843

Pákáski, 2008, Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease, Neurochem Int, 53, 103, 10.1016/j.neuint.2008.06.005

Chételat, 2010, Relationship between atrophy and β-amyloid deposition in Alzheimer disease, Ann Neurol, 67, 317, 10.1002/ana.21955